APA (7th ed.) Citation

S, S., C, P., P, V., G, N., S, R. K., S, I., . . . R, R. (2011). Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: A randomized clinical trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 53(7), 716. https://doi.org/10.1093/cid/cir447

Chicago Style (17th ed.) Citation

S, Swaminathan, et al. "Efficacy and Safety of Once-daily Nevirapine- or Efavirenz-based Antiretroviral Therapy in HIV-associated Tuberculosis: A Randomized Clinical Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 53, no. 7 (2011): 716. https://doi.org/10.1093/cid/cir447.

MLA (9th ed.) Citation

S, Swaminathan, et al. "Efficacy and Safety of Once-daily Nevirapine- or Efavirenz-based Antiretroviral Therapy in HIV-associated Tuberculosis: A Randomized Clinical Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 53, no. 7, 2011, p. 716, https://doi.org/10.1093/cid/cir447.